Erratum: Use of bivalirudin during percutaneous coronary intervention in patients with diabetes mellitus: An analysis from the randomized evaluation in percutaneous coronary intervention linking angiomax to reduced clinical events (REPLACE)-2 trial (Journal of the American College of Cardiology (2005) 45 (1932-1938) PII: S0735-1097(05)00672-8 and DOI: 10.1016/j.jacc.2005.02.074)